MIULI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 5.063
AS - Asia 1.243
EU - Europa 1.125
SA - Sud America 179
Continente sconosciuto - Info sul continente non disponibili 137
AF - Africa 25
OC - Oceania 6
Totale 7.778
Nazione #
US - Stati Uniti d'America 4.968
SG - Singapore 576
IT - Italia 480
CN - Cina 229
VN - Vietnam 151
BR - Brasile 145
RU - Federazione Russa 125
DE - Germania 117
BD - Bangladesh 109
IE - Irlanda 97
SE - Svezia 80
GB - Regno Unito 47
HK - Hong Kong 47
CA - Canada 45
FI - Finlandia 33
IN - India 33
MX - Messico 30
FR - Francia 26
NL - Olanda 26
TR - Turchia 21
AT - Austria 19
ES - Italia 18
AR - Argentina 13
PL - Polonia 13
KR - Corea 12
LT - Lituania 9
IL - Israele 7
IQ - Iraq 7
JP - Giappone 7
BE - Belgio 6
CO - Colombia 6
JO - Giordania 6
ZA - Sudafrica 6
HN - Honduras 5
HU - Ungheria 5
ID - Indonesia 5
RO - Romania 5
UA - Ucraina 5
UZ - Uzbekistan 5
CR - Costa Rica 4
EC - Ecuador 4
EG - Egitto 4
JM - Giamaica 4
MA - Marocco 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
BG - Bulgaria 3
CH - Svizzera 3
CL - Cile 3
EU - Europa 3
GT - Guatemala 3
IR - Iran 3
KE - Kenya 3
PK - Pakistan 3
PY - Paraguay 3
SA - Arabia Saudita 3
BO - Bolivia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KZ - Kazakistan 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
KW - Kuwait 1
LK - Sri Lanka 1
MY - Malesia 1
PE - Perù 1
SV - El Salvador 1
TO - Tonga 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 7.644
Città #
Singapore 449
San Jose 329
Ashburn 321
Council Bluffs 222
Dallas 147
Chandler 143
Los Angeles 118
New York 97
Dublin 95
Munich 80
Beijing 69
The Dalles 62
Santa Clara 56
Atlanta 51
Milan 49
Ho Chi Minh City 46
Rome 45
Denver 43
Hong Kong 41
Princeton 36
Orem 35
Boardman 34
Chicago 30
Phoenix 29
Hanoi 28
San Francisco 25
São Paulo 24
Montreal 20
Redondo Beach 19
Moscow 18
Washington 18
Buffalo 17
Columbus 17
Memphis 17
Scafa 17
Altamura 16
Brooklyn 15
Hefei 15
Helsinki 15
Bologna 14
Boston 14
Tongling 14
Düsseldorf 13
Stockholm 13
Da Nang 12
Turku 12
Warsaw 12
Chennai 11
Mexico City 11
Toronto 11
Florence 10
Jacksonville 10
Pescara 10
Wilmington 10
Frankfurt am Main 9
Houston 9
London 9
Nuremberg 9
Silvi 9
Vienna 8
Haiphong 7
Seoul 7
Shanghai 7
St Louis 7
Tokyo 7
Bari 6
Brescia 6
Brussels 6
Cleveland 6
Guangzhou 6
Amman 5
Amsterdam 5
Augusta 5
Baghdad 5
Chieti 5
Falls Church 5
Johannesburg 5
Lappeenranta 5
Mumbai 5
Naples 5
Philadelphia 5
Raleigh 5
Reggio Emilia 5
Verona 5
Ankara 4
Can Tho 4
Charleston 4
Charlotte 4
Dong Ket 4
Gwangju 4
Istanbul 4
Kingston 4
Lauterbourg 4
Miami 4
Ninh Bình 4
Norwalk 4
Piracicaba 4
Poplar 4
Romola 4
Tappahannock 4
Totale 3.337
Nome #
The benzydamine experience: a systematic review of benzydamine abuse 1.063
Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review 771
Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants 534
“Purple Drank” (Codeine and Promethazine Cough Syrup): A Systematic Review of a Social Phenomenon with Medical Implications 508
Misuse of Anticholinergic Medications: A Systematic Review 467
Over-the-counter Psychosis: A Systematic Review of the Misuse of Antihistamines, Cough Medicines, and Decongestants and the Risk of Developing Psychosis 391
Exploring peripheral biomarkers in psychostimulant use: A systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors 264
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study 186
Transcranial Direct Current Stimulation Reduces Craving in Substance Use Disorders: A Double-blind, Placebo-Controlled Study 166
Hypomanic/manic switch after transcranial magnetic stimulation in mood disorders: A systematic review and meta-analysis 137
Hopelessness, dissociative symptoms, and suicide risk in major depressive disorder: Clinical and biological correlates 124
What role for cognitive remediation in the treatment of depressive symptoms? A superiority and noninferiority meta-analysis for clinicians 122
Recovering from depression with repetitive transcranial magnetic stimulation (rTMS): a systematic review and meta-analysis of preclinical studies 116
Beyond the efficacy of transcranial magnetic stimulation in peripartum depression: A systematic review exploring perinatal safety for newborns 114
Exploring dopaminergic transmission in gambling addiction: A systematic translational review 114
Impact of sleep disorders and disease duration on neurotrophins levels in cocaine use disorder 112
Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis 106
Non-invasive brain stimulation targets and approaches to modulate gambling-related decisions: A systematic review 105
From a cycle to a period: the potential role of BDNF as plasticity and phase-specific biomarker in cocaine use disorder 105
Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder 104
Delirium in COVID-19 patients: a multicentric observational study in Italy 104
Craving and Other Transdiagnostic Dimensions in Addiction: Toward Personalized Neuromodulation Treatments 103
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice 102
High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young Adults 97
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 95
Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels' Decline: A Narrative Review 94
Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine 92
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review 92
Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study 91
New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances 91
Transcranial direct current stimulation for Phantom Limb Pain circuitopathy: Efficacy and safety in a patient with a cardiac defibrillator 91
Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature 90
Club Drugs and Psychiatric Outcomes: A Descriptive Case Series from Spain 89
Brexpiprazole as a new approach of treatment in somatization disorder 88
New psychoactive substances and suicidality: A systematic review of the current literature 88
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review 86
Alcohol Use Disorders and Suicidal Behaviour: A Narrative Review 81
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial 81
To bridge or not to bridge: Moral Judgement in Cocaine Use Disorders, a case-control study on human morality 74
Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release 72
Investigating the Role of Maintenance TMS Protocols for Major Depression: Systematic Review and Future Perspectives for Personalized Interventions 62
Corrigendum to “Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine” [Brain Stimul 16 (2023)] 61
Oral and Long-acting Injectable Aripiprazole in Severe Mental Illness and Substance Use Disorder Comorbidity: An Updated Systematic Review 36
Clinical Management of Synthetic-Cannabinoid-Induced Psychosis: A Systematic Review of Treatment Strategies and Outcomes 31
Novel psychoactive substances (NPS) as a risk factor for psychosis: A systematic review of the literature 27
Alcohol vs. Cocaine: Impulsivity and Alexithymia in Substance Use Disorder 25
Meta-regression insights for optimizing accelerated neuromodulation protocols in major depression 24
Eco-Anxiety and Mental Health: Correlates of Climate Change Distress 24
Exploring Dual Diagnoses: Psychopathological Characteristics in the Co-Occurrence of Schizophrenia and Addiction – A Scoping Review 22
Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes 21
Anomalous self-experience in schizophrenia spectrum disorders: Phenomenological and psychopathological correlates 19
Treatment effectiveness and preference in patients with schizophrenia switched from oral standard of care atypical antipsychotics to aripiprazole once-monthly: a brief report over a six-month period 16
Totale 7.778
Categoria #
all - tutte 25.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.211


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022105 0 0 2 13 11 4 3 13 8 9 9 33
2022/2023408 26 55 26 26 33 88 19 44 68 4 10 9
2023/2024312 20 17 26 7 30 81 48 12 9 20 9 33
2024/2025845 59 108 77 37 34 31 44 32 62 115 134 112
2025/20262.757 177 122 213 283 276 152 316 197 295 231 306 189
2026/20273.227 980 1.360 887 0 0 0 0 0 0 0 0 0
Totale 7.778